Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Sands

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Clinical Genetics|May 1, 1980
Mental retardation in association with a balanced X-autosome translocation and random inactivation of the X chromosomesM E Sands
British Medical Journal|April 29, 1972
Alginate casting method for recording dermatoglyphsM E Sands
Journal of Mental Deficiency Research|June 1, 1973
A possible case of partial trisomy for chromosome 22M E Sands
Journal of Mental Deficiency Research|December 1, 1974
A possible case of partial trisomy for chromosome 22: further evidence from Giemsa banding studiesM E Sands
Lancet (London, England)|September 29, 1979
Lymphocyte capping and carrier detection in Duchenne muscular dystrophyM E Sands, R Harris
International Journal of Radiation Oncology, Biology, Physics|January 1, 1995
Influence of radiotherapy on node-positive prostate cancer treated with androgen ablationM E Sands, A Pollack, G K Zagars
International Journal of Radiation Oncology, Biology, Physics|January 15, 1995
Local treatment for prostate cancer: 90 years later--response to M. V. PilepichA Pollack, G K Zagars, M E Sands
The Journal of Urology|May 1, 1994
Early androgen ablation for stage D1 (N1 to N3, M0) prostate cancer: prognostic variables and outcomeG K Zagars, M E Sands, A Pollack, et al.
Urology|August 1, 1994
Serum prostate-specific antigen, clinical stage, pathologic grade, and the incidence of nodal metastases in prostate cancerM E Sands, G K Zagars, A Pollack, et al.
International Journal of Radiation Oncology, Biology, Physics|April 30, 1995
The source of pretreatment serum prostate-specific antigen in clinically localized prostate cancer--T, N, or M?G K Zagars, V S Kavadi, A Pollack, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Clinical Genetics|May 1, 1980
Mental retardation in association with a balanced X-autosome translocation and random inactivation of the X chromosomesM E Sands
British Medical Journal|April 29, 1972
Alginate casting method for recording dermatoglyphsM E Sands
Journal of Mental Deficiency Research|June 1, 1973
A possible case of partial trisomy for chromosome 22M E Sands
Journal of Mental Deficiency Research|December 1, 1974
A possible case of partial trisomy for chromosome 22: further evidence from Giemsa banding studiesM E Sands
Lancet (London, England)|September 29, 1979
Lymphocyte capping and carrier detection in Duchenne muscular dystrophyM E Sands, R Harris
International Journal of Radiation Oncology, Biology, Physics|January 1, 1995
Influence of radiotherapy on node-positive prostate cancer treated with androgen ablationM E Sands, A Pollack, G K Zagars
International Journal of Radiation Oncology, Biology, Physics|January 15, 1995
Local treatment for prostate cancer: 90 years later--response to M. V. PilepichA Pollack, G K Zagars, M E Sands
The Journal of Urology|May 1, 1994
Early androgen ablation for stage D1 (N1 to N3, M0) prostate cancer: prognostic variables and outcomeG K Zagars, M E Sands, A Pollack, et al.
Urology|August 1, 1994
Serum prostate-specific antigen, clinical stage, pathologic grade, and the incidence of nodal metastases in prostate cancerM E Sands, G K Zagars, A Pollack, et al.
International Journal of Radiation Oncology, Biology, Physics|April 30, 1995
The source of pretreatment serum prostate-specific antigen in clinically localized prostate cancer--T, N, or M?G K Zagars, V S Kavadi, A Pollack, et al.
Pageof 1